Namenda Product-Hopping Ruling Opens Door To More Claims
The Second Circuit has become the first appeals court to rule that drugmakers may be violating antitrust law by withdrawing an older version of a drug from the market to force...To view the full article, register now.
Already a subscriber? Click here to view full article